AI in Biopharma Innovation and Regulatory Challenges – with Nishtha Jain of Takeda Pharmaceuticals
Emerj - AI Research
Aug 11, 2025 10:00
Emily Smith
1 views
airesearchbusinessapplications
Summary
Biopharmaceutical companies are rapidly adopting AI to streamline drug development, a process that typically costs between $708 million and $1.3 billion when accounting for failures and capital expenses. While AI offers significant potential to reduce costs and accelerate innovation, the sector faces complex regulatory challenges that must be addressed to realize these benefits.
As life sciences organizations race to adopt AI, the biopharmaceutical sector remains one of the most complex and high‑stakes environments for implementation. The median cost to develop a new drug is $708 million, according to the RAND corporation, rising to an average of $1.3 billion when accounting for failures and capital costs. According to the […]